Ch¥tty Tr9lstr#tion wmber 1143743
Compary registration Nmber07767248 (England and Wales)
THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2021
*A8CP4QRHC'
1610912022
OMPANIES HOVSE
A21
#157

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
LEGAL AND ADMINISTRATIVE INFORMATION
Trustees
Mrs MKhaela M Rees Jor*s
Mf Mawice H Craft
Joftalhan S M Craft
Mr Percy Bet*Jey
Mr J FTa
Ambassado
Mrs lfjrsty Ettrick
Mrs Chèryl lthitehead
M5 Tiffany Chawner
Ms ￿)la Floyd
Mr j￿lan O'Del
Mrs Caterna Ut)el
F¥tro
L(*dHAar￿e C
Bwry Boas
Roger Cadbwy
HarohJ & Daphne CooFer Charitable T￿￿t
Peter & Martyn Cooper
Jthn Ernery
Isthl Eitedgui
The Falkjn Famty
Leonard & Reree F*nstein
Charles & Clane Her￿nger
hael & Lolie H￿ller
Bob Lefroy
Be*s Malim
Marlin O'c￿l￿)r
&r MKhad Pathson CBE
S4r pa￿ & Lady Rudthk
Iw)r & ISa￿le Std(
Chris Sharp
ch*a M Rees Jones
Secretary
Mrs Joyce Fletdw lJ.P.)
Charity number
1143743
C￿npanY number
07787248
Principal address
2 Regèncy CPwThbers
Bwy
La￿aShire
BL9 CUW
Règistered offic•
Jthlee Way
Bury
Lancash¥e
BL9 QJW

THE HILARY CRAFf CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
LEGAL AND ADMINISTRATIVE INFORMATION
Auditor
J3ck50n Stephen LLP
Jarnes House
Stoneryoss Busvw P•k
Tree Way
trington
Cheshwe
WA3 3JD
Bank•rn
Ycfkshire Bank
&9 The RodE
Bury
. BL9 DYB

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
CONTENTS
Pag•
Chalman's ststèm8
Trustees. rewt
Statemen¢ ofTfUStees' Tesrwsil¥htres
Ind•pondent auithtofs rep)rt
9-11
Statementoffinanrialae￿￿theS
12-13
14
Slalement ofcash Ibws
15
Notes to Ihe fv)￿l￿al slalenwts
16-23

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
REPORT ON BEHALF OF THE CHAIRWOMAN
R?R THE YEAR ENDED 30 SEPTEMBER 2021
As v41th the maN)rity of charitiès tht Ccmd 19 pandern￿ ha5 sevÈfety affeded the abl￿ty to raise fthds. Th•
continL*d travel rè51ridions rneant Ihat no raisry events were Fossible in the year and the level of income has
¢ontinLpd 10 be Sub51antia￿ bek)w those athieved wior b) Cwd 19. It bè scffte twnè before thè sitLAtic
retums to nowmal and the income ￿Ve1 for Ihe coffwrvJ year ￿ Unth)￿1tedty be belrmt rwnal expectstsons.
Oe5Pite these wobierns there have been posiiNe resuls from ow fijnthry of cryhtinued research as ouuined in the
publirath)ns in medical joumals as detai18t1 li the RepJ1 of the Trustees wthin Ihese financAal statements. The
researth continues at lrnpeiial Comege L¢￿￿ and Ihe c4 Sussèx wherè Professor ￿910S Glamas
continues to mak• sxogress on d￿ek)K¥￿￿I ol an anti LMTK3 d￿￿. There are many n￿)re research proj&ds that
the Charity wi)uld wish to SUFWrt this be ￿tr1ded rfthe level of funds raued c(M*inues at the cwrent rate.
A major legacy of my vlife and the pre¥kx￿ Chairwornan. Hilary Craft OBE was the fowKlatk)n of thi5 Charity. and al
the Trustees a￿ deternined to continue to fijnd Ihe irnp)rtant plOre￿Tr9 research work that I supports.
personalty would Ike to ihank ihe Patrons. Ambassadots. indmduals, CA)mpanEs and charitsbk irusls and
loundati¢)ns who continue lo support Ackn Against Carter. My W is that tog•th•r wè T•AI be able to raise Iha
ds req￿￿ to o)nthiue the Imwlant researc*.
aurfce H Craft
Tru
ee
Oatèd.. 29 Jlty 2022

THE HILARY CRAFT CHARrrABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
TRUSTEES, REPORT (INCLUDING DIRECTORS. REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2021
The TnJ$leès prtsent th*r report andfmaneialstatements kn the year ended Xs September2021.
The finandal statemenls have been Fyepared ID wilh the ai>)xmiry poSi¥e5 set out in note 1 to Ih
rinan¢i?l $taternents and compty wth the tharity's govaning douynent. the C¢)mpanies Act 2006 and
"Accountin9 and Reportww ty Chafilies". Statement of Recrynmended Prtctth apph'cable to thawiti2s preparing
theSr acwunts in acc¢ydance with the Fina￿¥81 ReFryting Slandard applrtable n the UK al￿ Rep￿￿ of Ireland
IFRS 1021 (effective 1 January 2019)".
ObjoetTrves and activltles
The objectivès of Ihe tharity ha¥e remained undonged. These we kn ￿￿)mote and wotect Ihe health of the
wblK, ￿ particular ty research wrtti the prewtH￿. treatsneni and tsjre for ￿1 fonns of Cancer. This inclut1es
researth into practical applicatKJnsts the pre¥entw,treatrnent and cwe ofcancer and to di5sefflu)ale the usefvl
resuhs of $uth reseafth to the put4ic. The Charity Commissh*'s genernl guidartce ¢)n pubh"c benefit has been
referred lo when reviewing airns and ￿'earleS and in p1aftnw￿ cyJr fuiwe athb"es.
Sclentlfic Advisory Board
Aclx)n Against Cancer is wp4ileged that the fc41)wry suenlists WKI thpians have yeed to seNe on our
ScientifKAthsory Board..
Prolessor Heini.Josef Lenz - Director for Ckntsl Resea￿* and Ct>Head ol the Gl Caneas Pfogran USC
Norris CompTehensNe Cancer C*)tre. Prnfe5sor of MedKiie ￿ PrewentatTrie Me¢icine, Keck School of
MedirAne. Unpièrsity of Southwn Cawomia
DrAbby Sie9el-Assistanl Professor. D*partrTWt of Medi(ine. C¢)lumbia UnpM5rty Vedtsl CÈntre. New Y¢)Tk
Dr Stdthartha lthjkheqee . Assislant Professor. Department ol Medicffie. c0￿MÈla. UnNwsty Meth'cal Cenlre.
New Yuk
Piolessor Pramod K. Siiwdsts¥a. D￿e(￿or. Cam* aTrJ Ray Neag CMwehensNe canCerCent￿. Connedicul
Research Them•s
All wcrfk lunded by Ackn Againsl Cancer fats ￿derthe fol(Mng researththemes..
Cancer Stem Cdls
Geneticswitches
Developing a drug fcrf a totalty nvwapproach trj thernpy (LMTK3)
Understanthng the Cancer 8rn
Metastasis
n¢er Stem Cè115
Cancer Stem Cells {CSCsl onty constibjte w) to 5% of a canceThs tunI￿r. trmjt bw generate the fast M￿ti￿Y1ng
cells that make up the majoiity of the resL CSCS are also ￿ked to some of tr)e most malignant lealures of
cancer, Inc1￿j1ng Ireatment rÈsistsncè and fv at4ty to spread kn Other parts ofthe t￿dy.
ft can be many months ¢x even years aftw successful treatrnent of a prtsnary tumouT. before secondary cancer
spreads. This has been des¢thd as rf the dartddi￿ has been removed from tr* the CSC root is left
below Ihe Surfa￿ to regrow at a laier d*.
Adion Against Cancer is a number of pr*cts eX￿inry CSCS. to enatle Ihe devdok¥n￿t oftreatments
thal specffically target Ihern - to more ftjfy (xrt ￿nCerS wi by Ihe roots. The 5(aenti5ts are Work￿79 to gain a
thorough undetst3r￿1ng of how CSCS Op￿￿e and to answermtal questI￿S suth as".
. ￿Y do certain patients Th)t reS￿￿j to trealm￿ts?
. IAffiat ce4)dil￿$ $￿e ttunows to swe*J ar0￿d tt* body?
. Fbjw could firture treatrnenls spe0fiC￿ty Wet the most malignantce15?

THE HILARY CRAFT CHARITABLE FOUNDATION LIMtTED
ACTION AGAINST CANCER
TRUSTEES. REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED)
R)R THE YEAR ENDED 30 SEPTEMBER 2021
EXA￿LE OF PROGRE
Aciion Againsl Cancer is fundin9 an inno￿tiVe cancer stem cells resèareh rKoieth by Pwfessor Ju$￿'n
Stebbing arKI Dr Nina ModeFaU at ImFerial College Lortdon. They are devetcoiwwj a crmbination of new tools and
techniques for breast cancef palients. to ￿derstan(l Iheir Se￿ndary tumours befo￿ they even devèlo
It is not Ihe rxirnary tumour that causes latalty for most ￿$t ￿Cer pati&)Is. trArt Can￿r spreading
{rnètastasisingl around the body. Fty t¥east caTh, the Ser￿dary tv meta5tab'c lumou￿ develop ￿ the txain.
bones. Iwtgs LY INer.
Despite carefvl 5tudtes, it is stl unkno￿ how ce15 decidè %¥there they will migrate to and LYOW tumours.
One of thè maj.or fadors Ihat make it so to canw spre&d. and Some th&awes are
ineffeclivè. is tumour hetero9enwty. This characterith cl a tLffiour dexribes ts ¢omplex comp0s￿On with rnany
genetic mUta￿On&
The key Obje￿￿È lor the fnt sla9e ol this gr￿￿the￿ng research was to devdop a b￿ast caneer m&ael Ihat
addresses the issue of htlertsJÈnetty. This has been achieved. and the modd is atready Proving invaluable
furthering research in Ihis ehallenging area. For examr4e, the team wa5 able to use tt to disrA7ver which particular
rancerous mutats.ons are ￿p*￿e of invasion into INer arwj grow Ihere. and vthich a￿ not. It 15 antiC4paled that
as this reseafch conbnu•s rt wiu wove ofirnrnense ts￿fil to patients *rylh v•10￿ typès (rfcanc8r.
Genetic Swhches
Since the mapping ol DNA tmth the Human GerKJme Prw( the￿ is 9Wter understanding Wthin the seientift
community of some aspects of In Ihe past. the vast maJ"oiity d ONA bdieved to bt 'jw)k' as it tjoes
not code lor protein. 11 was thought ￿ a small arno￿1 of was 5¥Jnfficanl. fvt which iums into single
stranded RNA, and then into protwns for the str￿Te5 anlf I￿a￿)n$ we are lamitsar wilh Ibrovm
hafjr. blue eyes etel.
However, ft is now known that muth d DNA is in fact transuibed into non¥codirrfJ R￿As. some of whith play
irnportant roles in normal b1¢￿gical function. g￿e re9ulatirm and ￿nCer development. Action Atydinst Cancer i¥
Jnding a rangè of projects rdated to Idents.￿'n9n0n￿jlng ￿￿￿$ that are QFerating as genelic s%wtches causing
¢•n¢er to grvw or s￿IrL￿.
EXAMPLE OF PROGRESS.. TLYn
Funded by Action Against Cancer, a team led ty Dr Leandro Castellano al The Unr¥ersty of Sussex, 1$
investigating a dass of small RNA mr4Ècules eallÈd miryoRNkn These can ￿￿K)t# a transfmiicm of nofmal
edls into cancer ￿115 in 1￿Man bcwth"es.
Most microRNAs are p¥oduced in cem5 by zn enzyme ¢*d Orn. To sbjty how Chcer reg￿a*S ¢ellular
transfomial¢on. the team shut down ils expression in cancer cells usiig next-9Èn•ration sequenring. This
strategy Simultaneously e￿￿atpA hth¥ nett¥￿$ of gene interacbon5 COOFerate With M￿roRNA$ to promoie
catKef prtsyrèssion.
By using this approach the team discove￿. the fitst time. that c**-(thredty and independenyy tLvns off the
eXPrès￿On of one ol most ￿werful genes. c-ltyo
This gene is very diffic￿t to tsrgtt thernpeub¢*ty. but Ihese new findirmjs indrale that by modulating Di
activity wth chemKal inhibitors, c-myc acbvity be directy lumed off to fi￿t taneer. This is an extremely
prom15ing developm￿1 for Pati￿ts.

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
TRUSTEES. REPORT (INCLUDING DIRECTORS. REPORT) {CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2021
De￿￿>Ping a drug for a totslly new appToa¢h kn Ihèrnpy ILMTK31
The K1èntrficalion of a rw ¢arKer caus4)g gene in 3)11 by Pthssor Georgw G￿rna$ was the earf￿$1
significant breaklhrou9h supported by ActTh Against Canw. This gene ralkd LMTK3 is ntht lo humans, and is
expressed fflofe th canw ¢dls Ih*¢ in norm81 ￿1$. cancer¥ that have hvJh thls of LMTK3 a￿ also
muth rn0￿ a99￿$$1¥•.
Snce 2011 we have lunded resèarth aining 10 de¥elop w anl￿LMTK3 dn&. Tli5 woulj bè to over￿Me the
resistance to Ireatments that often develops v4ilhirt patiènts, bcKlies.
Many patsents respond wen to initsal treatfnenl tsjt Ihen develop resistance to il - this is when, with ojtrentfy
avallable treatments. their cancer becomes much more to treat. A potential antsLMTK3 drug wiu te
sperifically designed to woth in cor¥unction wrfh a patient's ￿$1kng ￿alMent and in a way that overcomes
hemolheopy or homional therapy resistance. aifown9 Ihese tfeatsnents to start ¥nrking again. Thi5 would be a
M￿ent0￿$ slep in the history ofcanrer trealmenl
EXMIPLE OF PROGRESS.. D
After yeaTS of devel4Mng LMTK3 speufic t1rugs. the team at the Unp4ersity of &Jssex is now worknng on
opts"rnlsing these and tesb.ng them in v*ityJs modds. They ha%E eslablished *¥J validated differenl types of
models for various experiments ar¥J I￿￿￿JaI￿e prcttthres. These Twa te used to ex3mine and clarify the
mechanisrn of a¢ts"on ol these novel dftwJ comwunds. In addrfion. how specifKally and effectNely Ihe eompDund$
work lo reduce tumour grtr•Ah w￿11 be lested. TIMS work is crucaal bèfofe pmgressing to thè next preth¢lnical and
dinical stages, where the a*n is to lest the bèst of Ihese dr49$ n pat*nts.
The an￿1pated abAity of LMTK3 in7&Jitors lo overcoff* I￿atMert resistance offèrs ènrnus hope for huge
numbers of peo￿e.
Underntanding the Can￿r Brn
is thought that ceJ¢s ha¥e a'brain.. which is reS￿sIb* ts tum4)g the 'on' or'oif. ￿ are fundi09
research tO9ain a ccfftpr*hensNe understanding ofthis cwwbrain. by ￿aMIng exath what lakesplace duiing
on$et and 9rTrHth of cancer- one prottin at a lime.
Proteins are present in al of the cd15 in body. in car￿r cells. The types of proteins. their quantity.
and the level of their adswty can flther between nc￿81 cels and ¢2ncer cels. Prote￿ enable can￿r cells to
9row very fast or Ihey can ¢ausÈ them not to respond to a given drug. One of the main approaches in studying
cancer¢ells end idefttfying new Iwlrnent tsrgets i% to analysetheirprotein content in great deta￿.
Ath"on Aganst Cantèr sw)porfs researeh to LwK1erstand ¢ancer ￿4$. to the way for the de$4n ol thg$
targeliThJ tho* proteins that are fwrvl to play the most irrportant ￿ in ts progression ofcancw.
EXAMPLE OF PROGRESS: C
By encouraging can￿r célls to Change into normal cdts. diiferentiation It￿apY cgxld offer 3 groundbreaking
treatment opt￿n for cancer palienls. It WOLld also redvTr the prot4￿$ of tox￿ ol more conventional
Iments such as chemotherapy and radiother4w, t*W generally invc4¥È killin9 Iwnour ce115. DrfFerenliation
Iherapy is ￿ altemalive Ihat oknate this woblem ￿ the treatment of a¢fvanced cancers.
Supported ty Action A￿n$t Cancer. a team has demonstrated h(w4 a speryfic enzyme la type of protein) is
involved in ehangln9 brain ￿nCer tels bath into ceus. conknues in exLating area lo futher
exarnine this enzyme and its potentsal to hèlp pa￿￿ts.

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
TRUSTEES. REPORT (INCLUDING DIRECTORS. REPORT) {CONTINUED
FOR THE YEAR ENDED 30 SEPTEMBER 2021
P•lela$ts$is
lthen can￿r 15 saKI to spwead Ihis means it has metastssised. Thi5 is when cancer ¢e15 break away from
where Ihey fitst fomied and travel through fv bk¥yl rx tymphalic systems kn lom) new lumours in other parls of
the boty. This development of seo)ndary is ￿lled metaslasis. A metastatic tumour is the Same type of
ancer as the wimary bjmow.
Ad¥)n Against Cancer funds a nwthr of woiecls that *e linked lo ￿derStan￿n9 the causes ol metaslasis, in
Order to..
. more effedi¥dy Ihe Ske1￿￿)d cl ce15 rnelaslassiryj (ssyeathgl in each pthnt.
. tsilor the tesling for patients with a hwjh fthekhood of tF)w meta51asising SC* as Ihe
likelihc*)d of early thagnosis.
. imwoNE the treatrnent slrategkn Iyjr ttEse pati￿ts for metastasis ol tr*ir cancer has
EXAMPLE OF PROGRESS. T
Triplè negative brèast cartter is often rn0￿ a99re$5pR, metaslasising ffKJre effectivety Ihan olher bmst ￿cers.
Action Against Cancer is suppothg research u)to *lentsfyty recepttys that sperAfitalty dwi¥e thi8 type of canw,
lo be able lo target them and treat pat￿ts.
Usffio an innOvab￿ stratègy. the team fThT Klentsfied. for the first lime. that 8 subset cl such molecules is
an importanl drivef oltrlple negalNe breast ￿¢¢r and IW these can be used a5 laih)Ted Iherape¢Jtic targets to
treal this notoriousty difficutt disease.
Ach1ewe￿ts and perfomw￿¢
Oue to the Co¥id pandefflic, Ath"on Aganst Cancers incoffie has ctsthued to be at a muth lower level than
durlng prè-pandemic times. A number of I￿￿raI￿ng events or9arMsed by 5VPPOrter5 for Action Against Cancer
across Ihe wintry were ￿stp{Thd ry canc4fed. Support from in¢JMduaL8. c¥)mpanies trusts and foundakn.ons
was alsosignbficantiy re(bJced. resLlh"ng in less funds raised rèsearch into canc*r.
However. all at Acti￿ Ag￿st c￿cer *e gratefvl to Ilw domrs supwjrtets who were still able 10
donale towards our work. a￿ also extre* ol thè weat work the saentists werè abte to c￿ltInUe
despite thè many ¢*ificults"es Ihw fa￿d.
Below is a sample ol p￿iShed p•per$ desoibing pwfy fijnded byAdIC￿ Agafftsl c￿Cer..
1. ce￿derNed extracelldar be used a$ a t•Jmather reseNoir tor gr￿*Las1Oma lurTV subtypin9
2. Breaking through thè 91ieblastoma micrtrenNironrnent ¥ia ex1ra￿lIuI8ryeSldeS
3. The rnultifaceted role ol lemur tyrosine kinase 3 in heamh and disÈase
4. Muftinational landxapes ol norn￿1 t*east thimg age aThY we￿n¢Y ￿teM￿& cancer risk

THE HILARY CRAFT CHARITABLE FOUNDATION UMITED
ACTION AGAINST CANCER
TRUSTEES, REPORT (INCLUDING DIRECTORS. REPORTI (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2021
Financlal veview
During Ihe year the tharitys income ai so￿$ arnounted to £289,334 (2020.. £202.5251. kn the sarn¢
period. expenditure on chartsble acMRs totsmed £1.028,978 12020= £735,594), aTrJ the cosl of raisir¥J fund5
totalled £69.4S912020: £73.7401.
Accumulated fvnds as at Xl Septernber2021 lolalled £2.225.OC6 (2020". £3,034.1091. The Trustees consider thal
the finanual posrfion as at 30 September 2021 1$ salislactuy. Apprwmatety IWC￿thifds tl Ihèsè lunds (Includirwj
lha￿ in uNestrKted fiJThJsl ha* been awthed to aFvove(I ￿￿¢ts (set Ncle 131.
It is Ihe p0￿cY ol the eharity that uNestitted funds ha%E not been des¥Jnated ftr a specifie use should be
rnaintained at a level equNalenl lo belween Ihree and six nw)nths eXpend￿re. The Trustees consider thal
reserves at this level wll ensure tha¢ in the ewent of a signifvant diop #i fvnding. they wll te able to continue the
harity's current ￿til￿￿e$ ￿nSidera￿)n is given lo ways ￿ vthich additirThl h￿d3 may te raised. This level
of reserves has been maintained throughojt Ihe year.
Plans forthe lu￿re
The charity wil continue lo fvnd 11 d the ryoF¢ls already apwoved. aTrJ to frJThJfaise lo supwt other research
ainwng to frKlher understaThJ cav and hryi lo better diagnose aTrJ treat l The tharity wil continue to
di55eminate' results ol resea￿1 in wtthshed soenbk on the ¢¥yawisa1￿￿'s wpb>te aThJ in regulw e-
newsletters.
Structure. gowrnanco and managoment
The chafity is a company lirnitetl by guarantee. irwted on 8 Setrteth 2011 aTrJ registered with the
Charily Commission 9 SeF4effl￿T 2011. The chwity cwies its acti¥itsts using Ihe workirg narne Action
Against Cartw.
The Tnjstees, who are also the direct￿ fcrf the of cryny law. and who Sor￿ during th• yèar and up
to the date ol si9nalure ofthe fManC￿ 5ts1ements were..
Mrs Miehaela M Rees JLM￿s
mault￿ H Craft
Mr Jonathan S M Craft
Mr Perty eec￿tY
Laurence J F Tarfo
Hilary S Craft 08E
{Deceased 27 De(￿nbel 20201
The Board olTwstèes is aUthe￿sed to aFV)int TnJstees to f• varaMies arisiry the w￿3notion or
death ofan *￿StIng Iwstee.
None of Ihe Trustees ha$ any benefKial iF*west n Ihe AM of the Trustees are members ofthe company
and guarantee lo contribute £1 in thee%enl ofa wnding up.
The chaiity benefiis from the ryowsion of attomm¢)Jation administrati4E support from Regency Factor5 P
4 eornpany Ihat is eontrolled by cerlain (4 the Tnjstees of ihe tharrty. No monetary ￿l￿e can be attThtrMJled to Ihis
support, and the￿￿e l is not i￿lutsI vi the firwKial stalemènts.
There a￿ no other tran￿tiC￿$ wilh related paries. The Tntslees maintsin a register of interesls, whith is
upjated at every rr*elin9.
The Trustees have assessed the major risks towhith the th￿lty is e¥posed. are satisf*d that systems are in
F4ace to mitig* exposurè b the rnaitr rtsks.
Intemal control risks a￿ miThmi5ed ty the irrylernentstion of F*cttdures kn aulho￿atiOn of al transactions and
PToie¢ts.
Procedure3 are in ￿ate to eftswe *ilh hèath and safety of slaff. bxlunleers, d￿nts and Msitors.

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
TRUSTEES. REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2021
Audilor
The aurfrtrffj. Jac*son Step1￿ LLP. 15 deemed to ￿ reapp)ini8d ￿der sad￿n 487{21 ofthe Companies Act
2006.
Disclosure of inlormation to avdilor
Each of Ihe Trustees has confThed that Iherè 15 M infomlabon of whlth Ihey are aware is relevanl to the
audit bLrt ofwhich the a￿l￿or is ￿aWare. They have fither confymed Ihal they have taken apFiopri*¢ step$ to
Èdents'fy SLxh relevanl inforniation and lo e51at&sh that Ihe audrtor ps aware of such irrforrnthn.
behaff of the board of I￿￿teeS
Mauii¢g H Crnft
stee
Dated: 29 July 2022

THE HILARY CRAFT CHARITABLE FOUNDATION UMITED
ACTION AGAINST CANCER
STATEMENT OF TRUSTEES, RESPONSIBIUTIES
FOR THE YEAR ENDED 30 SEPTEMBER 2021
The Truste95. who are a￿0 the éiTedots of The Fllary &aft charitab￿ FourKJatrcx) Limited for the purposè of
company law. are responsit4e kn preparin9 the TfUSte•s' Repcwt and ihè financial statements in aC￿rdan￿ with
applicable law and United King¢Jom A￿)untr9 Standards (Lkntte(l Kirgdom Generalty Accepted AccO￿ling
Praciiol.
Company Law ￿qui￿ the Tntslees lo prepa￿ finarKiaT slatemenis each fin•nck31 year a true and
fair view ol the stsle ol affaws of the tharity and ol the incoming resources and apF4'catw of resources. including
the inc4Jmo •xpendiiurn, of th• chaiitat4ecornpanyfor thatyear.
ITh weparirvJ th?59 fmancTral statern￿ts. the TnJ5tees are requffed to: .
- selecl suilable accounling polcles and Ihen appPy them gxsistenty:
. obserye the fflelhods and winuples in the Ch*th"ès SORP:
- make J￿￿9enwts and thal are reasonabte
- slate whether applicable ix Accounting S￿dar¢s have been folk)we(l. s￿le(l to any malerial departures
disck)sed and explained n Ihe finaTh>￿ slateffl￿ts.
- prepare the finanual slaternents the gowy c(K￿rn basis unless it is WRPk¥opri*e to presumè that the charity
will continue in operat￿.
The Trustees 8r¥ respC￿SIt￿e l(* kewng atsquale aCCo￿tir￿> fec£ffds that di8cl)se with ￿a5cffiab￿ accuracy al
any time the financial p05itH)n of Ihe charity and erbable them to ensure th3l Ihe financi￿ stalemenls compty with the
Companies Act 2006. They a￿ also responsib￿ for safeguarding the assets of the thartty and thenee for taking
feasonable steps for the prevention 8fKI dele(aion of fra￿1 and other irrewtslibes

THE HILARY CRAFT CHARrrABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
INDEPENDENT AUDITOR'S REPORT
TO THE TRUSTEES OF THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
Oplnlon
ha¥e audited the fin¥￿1¥4 Statern￿t$ of The Fllary Cfaft Charitsble Foundation Lwnited (the 'charitrf) for Ihe
year ended 30 SeptÈmbtr 2021 Ythith cornprise Ihe statemènt ol financia ath"wties. the balar￿e sheet. the
5taiemenl of cash flow5 and the notes to the statern￿ts. i￿￿ld1[V4 a surnm*y c4 sKJnir￿nt accotsnting
policies. The financial reForting Iramehrrt Ihal has appfied sn Ih*r preparati￿) is ap￿￿ble law and United
K*)gdom Accounting Standards. indudry Financial Reptsrting Standard 102 Tho Financial R•￿￿￿"Ag Standord
apPI￿able in the UK and Repubk (rfJrelaNI (Uniled Generalty AcceptedAccounting Pradi¢e).
In our opinKJn. the financia ststeM￿ts=
gbve a Irue and la￿ wew of Ihe state ol Ihe itsilalè compantys affairs as at Xl Septwnber 2021 and ¢f Éts
incoming resources and applKation of res(yJrtes. for the year ended..
have been property prepared n acCOrf￿ with Unrted Gujernlly Accepl&J A¢cwnting Practice",
and
have been prepared in act£{d￿e wilh Ihe rew¥ements ofthe CryaniesAct 20C6.
Basls lor oplnlon
We conducled our au¢Jit ￿ ￿￿[dance Intemalional Standard5 on Au￿rtTr￿ IUK) IISAS IVK)) and ap￿IC￿)
law. Our fesponsits'lities ￿der Ihose standards are described in Ihe Audilofs respons￿"￿tieS lor the audit ol
Ihe financial Siatèrn•nts section of OLK rw. We are independent ol the in ￿OrdanCe *ith ihe ethic
requirements that are ￿levant to our auth"t ol the finaneial statements in Ihe UK inthding the FRC'S Ethical
Stsndard. and we have lulfiued ￿Jr olher ell￿7 resp￿S￿lI&1ieS in a¢eordarte Y+ilh these requirernenis. IAÈ bdieve
that Ihe audit e￿d￿ce we have oblYAned is suffKient appropriate to prowde a basis opNion.
Concluslons rnlath19 to golny concern
In auditing Iht ffinancial stst*nents, Me have conth¢Jed Ihat thè TNstees' use of the gc¥ng ￿)ncern basis of
accounting in the preparation ol ihe finantia sta￿lents is appropriale.
Based cm the w)rk we have perfo￿ed. identified any materiat relating to evenis or
¢onditions Ihat, indi¥it1ualty or coNecti¥dy. rnay cast ygniffi¢ant thsubt ihe charity's atsfity to conbnue as a gjing
concem for a perbjd of al least twel%E months from vthen Ihe fmancial statements at *Jlh)rised issue.
Ow reswnSbbifities and Ihe responsib￿llieS of Ihe Tfustees wilh respect tr> going corKem are desryibed in the
rel•vant secbons of this reporL
Other Inlorniaiion
The other inlornation c¢MN)rises Ihe infoffl)akn •) the a)nual other than the finarKxal ststement5
and our auditorfs report Ihereon. The Twstees are ￿[￿Sible fty Ihe oihef infomiabon contained v4ithin the annual
Tepcrt CKJr opinion on the financial statema)ts does not wver Ihe olhEr infomiatKJn and. eX￿pt to the extenl
0lhèThvise expltciljy stated in our report. we do ￿t express any kn of assurance condusion Ihereon. Our
responsbility is to ￿ad the other infrmalion a￿1. in doin9 so, con*dei whethef the other infomiabon is rnateri8lly
lnconsi5tenl￿1h the fmancial statements knO￿e obtained •) the COLKse of the audit. or otherwise appear5
lo be materially rnisslated. If we idenbfy such mat￿131 inconsislenries ￿ apparent rnaterial misstatements. we are
requirèd to detem)ine whethef this gives rise to a material misstatement in the fvlancial staternents themselves. If,
based on Ihe work we ha￿ perfom)8d. condude Ihat Iherè is a materia misstatement ol Itss other infornation,
we a￿ requifed to report that fact.
We have ￿1hing lo repcrt in this rwwd.
Oplnfons rn olhw matters prts¢nkned by the Companies A¢t 2￿8
In our opinion, based on the undertaken n the course of our aud￿.
the infomation wen in the Tru5tee5' report the fmarKial year for the ￿ancIal statements are
prepared, whth inchjdes Ihe d1￿CtorS. report prepared kn the purposes ofcompany law. is consistent wlh 1he
financial staternents- and
the directors. ieport induded theTrustee5' hasbeen prepwed ￿ accordarKe with appk¢abbp1È9al
uiraments.

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE TRUSTEES OF THE HILARY CRAFT CHARITABLE FOUNDATION UMITED
atters on 71thi¢h we ave rn4uired to rwirt bytxceplion
the light of Ihe knowledge and uNler5taTrJing of the thwity and its enwionmenl oblaine(l in the ￿TSe of Ihe
audit. we ha¥e Th)t identified matenal misstalements ￿ the directors. report t•nthin the Trustees. repD
the hght of the knowledgè and und*slanth& of the eompany and its envKonment obtantd fft the coutse of I
audit, we have not identified rnalerial rrMsstalement5 n the Tnjstees. ￿POrt. ￿ have r￿thIng to report in respe￿ of
the following matters bn r81alron to whth the Comwies Act 20[￿ requires us to wort to you rf. in OUfOWlllOn.
adequate accounting records hwe not ￿tfi kept. or ￿turnS adequate trx au(lil have not been recelved
frcffl branches not visited by us.. or
the financialslatements are not ￿ agreementwith the ac(y)unting record5 retLwn5".
certaindisdosures ollnJstèÈs'iemneratw)n spe(?fied by law arè nol made:
we have r￿t obtainttd al th• •*offl)ation aTh1 eyglanakn.orts Ihal C¢*￿idered necessary pwpose of
Jr audrt.. and
the Twstees were nol entilled to prepwe Ihe fmnlyal statements in aCC￿danCe with the small companies
re9ime and take a(fvantage ofthe small u)mpaniÈs' exemptions in preparing Ihe TFu5tees' report and from the
requireffl￿t lo prepa￿ a strate￿ rnporL
Responslbililtes of Truste
As explained more thjlty in the stattmtnt of Trusl•es' responsibilitses. Ihe TrustÈ8s. who are also ihe rfirectors of thè
ch8Fity for ts purp)se of ¢x)mpary law. afe responsiblè for the wepatakn of Ihe finarrial statements and lor being
satisfied that Ihey gi¥e a true and ts Ni￿. ￿ lor s￿* intemal control as the Trustees deiermw* is necessary lo
ènable the preparation of fnancial statemLbnts that are free frorn material mi5StatÈment. whèther due to fraud or
error. In preparing the fnanclal statdnents. Ihe Trustees are reSp￿Sible for assessing chaiity's ats￿lty to
rmtinue as a going concern. sJisdoyn9. as applicable. rnatteFS related to going concem aTrJ using the 9othg
corKern basis of accounb"n9 unless the TnJstees Wther intend to liqU￿at* th• charitable company or to ceasè
cperalions, or havè no realistic alternative but to do so.
Auditor's responslbllities for the audil of the financial slaternents
Our objectives arè 10 obtain reascffiabl& assurance about whethèr thè statements as a whole are free frorn
material misstaternenl, whether due to fraud or error. and to rsgje an au(lit￿5 report that includes opinion.
Reasonable assurance is a high level of assurance bvl is not a guarantee that an auflit conducted in accordance
with ISAS WK) will ahvay5 detèct a maten.al nmsstatement when rt exists. Misstatements can arise from traud ¢r
error and are considered material if. U￿wid￿ally ¢y ￿ Ihe aggwale. Ihey could reasonabty be e¥pe¢#ed to inflU￿Ce
the ecc*omi¢ decisions of usets taken cffi the basis of th￿ finanrial statements.
The extent to whil* our pr(Kedwes ¥re ¢8p*4e tsf ¢JeWng iwulaithes wKknJirwJ fraud. 15 detailed bebjw.
Based on our understanth'n9 of the chaEitab* cornparry and sectoi. ¥￿ identified thal ts winupa risks of notF
ompliance with laws and regulations rdaled to, but were not Iwnited to. Ihè Companiès Act 2006. the Charities Act
2011, erryloyrnent, pension and health and safety legisLatKin and we cijnsklefed ts extent lo which nor
ccfflpliance might have a materialeffect on thefinancial statements. ￿ also Conside￿ those laws and regulations
that have a difecl impact ￿ Ihe preparntion cl Ihe financial slatements suth as the Companies Act 20C6 and lh¥
Charilies. Statement of Rec(￿rnended Practice.
evaluated mana9ement's incentr¥es and Cfwtwiities for fraudulent marffjulation of Ihe financial statements
lincluding the risk of override of cc¥)trols) and deterniined th* th8 pnncyal risk5 were related to managemenl bias
accountin9 estirnatès and jud9emeths.
10-

THE HILARY CRAFT CHARrrABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE TRUSTEES OF THE HILARY CRA￿ CHARITABLE FOUNDATION UMITED
Our procedures to resF*)nd to risks identif*d ￿chjded the frJh)wry.'
re¥le￿ng Ihe ffnancial stalement dtscb)sures aThJ testin9 to supporiry ¢*)r)JnenlatbJn lo assess c*>mpli*xe
Ih provi5ion5 of re*vanl k8ws wuktbjns de5¢rW a5 havin9 a direct effect on the financial staternents:
enquiring of managemenl aiKSUt actual and wjtenlial Itb3atw and ¢13wns. their p)kties and p￿￿dureS to
prevènt and detectftaud as well aswhéthefthey have knowledge ofany actual. sus￿¢ted or alleged fraud;
perforrning anatylKal Pr￿edureS lo thitrfy any unusual or unexpeded relalionships that may ￿dICa(e risks of
material misslatement the to fralhl..
reading minules ol meets'ngs ofttr•xe charyed Mlh go¥emance:
oblaining an understanding of provisions and hokdin9 discuss￿S wilh managtment b) ￿detsI￿d the basis of
reojgnition or n0fvrec0gnrt￿Jn of provi5h)ns'. and
in addressing Ihe risk of fraud through managemenlo¥erride of controts= testing the approwiateness of joumal
entr¢es: assessing whether the acojunting esl¥nales, judgements and dwsK)ns rnade by managÈmenl a
dI￿tr￿e of a polenl>al txas," and evaluating the business rationale of any s￿n1ftant trnnsactions thal are
urtu$ual ortytsid¢ Il* nom￿1 ¢outse tsf busnwss.
We also communicaled relevant hlenttfièd rtguklK)ns and wtential fraud rtsks to all engagement team
membws and ￿m8¥￿d alert to any ￿d￿al￿5 of fraud or rorbllojmrkn wth kws and fègulatK)ns throughout the
audit.
Therè art inhef•nt limitai*)ns li audit tA￿edureS ¢knit>ed TIE I￿re rerrthpd that laws and
regula¢ipns are frorn fin￿al tr•sa¢tions, Ihe *ss &kety it is Ihat *e Y￿uld b￿rne aware of non-compliance.
Auditing slandards akn limit the authl procedures required to identify nOn-c4)mpkan￿ with Iw5 and regulatlgns to
enquiry of the directors antl olhei manwJement the Inspec1K￿ of regulatory and ￿gaI tx)rrèwndÈne¢. rf any.
Material misslatements that arise due to fraud harder i¢* dètect Ihan those that arise from error as they may
In¥0￿e deliberate Con￿a￿en1 ty ¢￿$*Y).
A further descr¥>lb)n of resp￿s1￿￿tieS is a4TaAat* on the FwiwKial Re￿)rtry Councifs vRtsite al.. htlp5.'11
www.frc.c¥g.uklauditOts￿$P0n&Th1blI•S. desclvlit￿ ofow auditjts repo
Use ol our report
This report 15 made solety to trE ch¥rttable compan￿$ rnembers. as a bo¢ty. in actordance vAlh Chapter 3 of Part 16
of the CompaniesAct 2006. (Jjr aw*1 vK*k has underlaken so Ihat we mvJht stste to the chantabfe companls
members t￿se rnatters are required lo state to in an auditors. report and for no other purw)se. To the
ful￿$1 extent pe￿illed by law. do noi accept or aSSLThe rÈsF￿nSIbllty to anyone other th￿ the charitable
cc¥Tr)pany and the charitab* c(¥npan￿s mernbe￿ as a tothy. br our wdit wrrfk. tr Ihis repjrt. or for t￿ opinions we
have foThr*d.
fda4r- Sl4L UP
Peter Alkinson F.CA. ISeDiw Statutory Auditor
for and on behall of Jackson Stephen LLP
29 Juty 2022
Chartèr•d Accountsnts
S1atutoryAurfrtor
James House
StonKr%)6s Ptyk
YewTree Way
cheSh￿e
WA3 JJD
11

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
STATEMENT OF FINANCIAL ACTIVITIES
INCLUDING INCOME AND EXPENDrruRE ACCOUNT
FOR THE YEAR ENDED 30 SEP7EMBER 2021
Cvrrentfwtancial y•ar
Total
To
fvnd5
2021
fvnds
2021
2021
2020
Notes
Vdunlaiy in￿$me
In¥estrr*nts
226.039
9.628
279.
9.628
175,040
27.485
Totsl incom•
235.667
S3,667
289.334
202.S25
endithre ow.
Ra5ing fijnds
69,4S9
69,459
73.740
Charitable actsvities
1.013.959
1S.019
1.028.978
735.594
Total
1.083.418
15.019
1.098.437 809.334
Net lexpenditureifincome for the yearl
(847.751)
38,648 {809.1031 16C6.8091
Fund balances at i O¢tober 2020
2.959.607
74.502 3.034.109
3,640,918
Fvnd balan¢•s at 30 S•pt•mb•r 2021
2.111.856
113.150 2.225,(￿ 3.034.109
Th• stalement of financial zetibibes incknjes a¥ pn5 * Io55es recognised in Ihe y￿.
l and expe￿￿rture C￿li￿1n9 xb¥it*s.
Thè statemènt of financial ￿ alsts with the rewyemerts for an income and eX￿￿ule attount
under the Companies Ad 20(*.
-12-

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
STATEMENT OF FINANCIAL ACTMTIES (CONTINUED)
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 30 SEPTEAIBER 2021
Piior finawKIBly•ar
UN•strictsd Restrlcted
fvnd$
funds
2020
2Q20
Total
2020
Notes
Income from..
Voluntsry
Investments
1￿,021
27.485
1S.019
175.040
27,485
Total income
187.9J6
15.019
202.525
•ndl
Raisin9 fund5
73.740
73.740
Charitable ac11v￿•S
702,751
32,843
735.594
Total
776.491
32.843
809.334
N•t l•xp•nditvrnifincom• forthe y•arl
Net movement Sn funds
1588.985)
117.8241 1606.8091
Fund balarKes at 1 Othter2019
3,548.592
92,326 3.640.918
Fund balances at 30 Sepl£mber 2020
2.959.￿7
74.￿2 3,034,109
The slaternent of financial ¥cb¥ities indudes all gains and ￿)sSeS le￿gnIsed in the ￿r.
All income and expenditwe deri4• from contiN•vJ acbwi*S.
The slaterrent of finanryal adi¥ilies *0 T•rilh th• ￿￿￿Ten￿nts br w irKomt and expenditLtre a¢count
under the Cornpanies Acl 2(￿.
13-

THE HILARY CRAFf CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
BALANCE SHEET
AS Af 30 SEPTEMBER 2021
zo
2020
Current assets
l)eblors
Cash al b8nk hand
10
381
2,302.991
381
3.133.361
2.303.3rd
3,133.742
Creditors". amounts fallng du• T*lth
on• y•ar
11
(T8.3661
199.6331
Nei cuffent assets
2225,1))6
3.034.109
Funds of the eharfty
Restricted funds
UnrestrKled tund5.'
General unrestrithd fiJrLd$
Designated funds
12
113.19)
74.502
641.9)3
1,469.953
431,359
2.528,248
13
222S.¢X6
3.034,109
The fnanrial stslemenl$ wwe apkYob*d ty the TnJste&s on 29 J￿Y 2￿22
r Mauricè H Craft
Company Registration Nty 0776724
-14-

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 30 SEPTEMBER 2021
2021
2020
Cash Ilows operntin9 a¢li¥itles
Cash absoibed by OF¢rat￿n$
16
1839,998)
1587.6261
In¥estln9 actlvities
Investmert income recÈi¥
9.628
27.485
Ntt ¢ash 9enernted fr(Yn Invesllng
activitiès
27,485
N•t cash us•d In flnandng actlvltles
Mel de¢rpase in cash and cash ¢4ui¥alents
{830.370}
1560.1411
Cash eguWa￿￿1s al b8ginrrirvJ of JE
3.133,361
3,693.502
Cash and rAsh equlvalents at end ol yèar
2,302.991
3.133,361
15-

THE HILARY CRAFT CHARITABLE FOUNDATION LIMrrED
ACTION AGAINST CANCER
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2021
Accounting polkies
Charlty lTrfornMtlon
The Hilary Craft Charitth Foundaiicffi bmited is a wwate company knited by guarantee itorporaled
Engl￿d *)d and a (ègtste￿d charity ond IA*s. The reWred olke L$ 2 RegerKy
Chamber5. Jublee Way. Bury. Lanra5hire. BL9 (klw.
1.1 Accounting eon¥entSon
The financial Stslements teen prepared in 3ccc*dance *ilh ts chaiity$ goveming drKumenl, Ihe
Comwies Acl 20C% "ACcoUntw￿ Reprykng by Chaiitss.. Statement of Recommended Practice
applicable to chant*5 prepamg their accounts in aC￿r￿M with Ihe F￿ancial Reporting Slandard
appltcabte in the UK and Repuknl￿ of Ireland IFRS 102)" (as amended for accoLmting periods ¢￿￿en￿n9
frorn 1 January 2016). The tharity is • Put* Benefft Entiy as defmed by FRS 102.
The fmanual $latements are prewed in $terfYy, is fWKlic￿ the charity. m￿etary
amounts *) these fin**ial ststements rowthd to the ntartst £.
The financial stslemenis have wE￿Ied the historical ￿1￿1 ¢￿11￿. Thè prvicipal acCO￿tirbg '
pc4ia•s adopted *e set wt tqhy*.
1.2 Going concern
Al the tirne of approwg the finwKial stalements despite the effect of Co¥id-19, the Tntstees have
reasonable expeetsticffi thal the ch*ity has adtquate resources to continue li operabonal existerte fe¢ the
foreseeable future. Thus Ihe Tn&stees to adLW the goin9 cwKem ba515 of acc(MJntWkg in wepwin9
thè financial statemènts.
1.3 Charit•b* funds
Unrestricied knds • WdrfaLqt fty use at the thcre1lL￿ of th• Tntstees in furlheranc* of Ihew ch*iabl8
objecb¥es.
Restrict&d funds are svbpct to speak cc¥)thtic¥ts ty donors as io how Ihey may te used. ThÈ purposes and
uses of Ihe reslrited ILThJs are set the notes to ihè &CL￿nts.
1.4 Income
come is recognised thanty is legally enblled kn it after any perforrnarte ￿nth￿on5 have been mèt.
the ancyjnls te measured ￿￿"abty. probat4È Ihatincome be re￿Ned.
Cash dwat1￿$ ore re￿gnIsed ￿ receipL Other drwlions are rwnised ￿ce fv tharity has been notif￿d
of the donatic¥). ￿lesS pertornianc• cefiditi.ons fequwe defewral of Ihe amount Income recoverable in
lation to donatrons rec2r￿d ijnder GiftAid or d￿d5 of covenant is recogTh5ed at the time ofthe dcffiation.
Legac￿ are recognised receipt or otheNin rf chawity has been notifièd of an Thpendng distributi￿.
the amtsJnt is known. and we•yt is expected. If is not knovffi. Ihe le9acy is treated as
¢ontingent asset.
Donaled are recogn¢5ed as incwne when Ihe chwity has c(mtrol over the item. any Condit￿)nS
associafed with ts itern have been MÈL the reteipt cl the economK b￿erit fr(Mn the use by the charity of the
item ¢ probable and tl* eetsntth￿ benefft can te reliat+y.
On rectpt. dcnated semces are rtcognised ￿ Ihe bas￿ of vabje cl Ihe gift to lh¢ charty Wh￿ is lh•
ount the tharty W1￿1d te ￿lig to FOY to oblain ser¥ices ￿ fxiliiies of equwatent economic benefrt on the
open mafket: a correspondw)g ¥ffio￿t Is recognis8d i) expendrturè n the peri(MJ of racèyL
16-

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
NOTES TO THE FINANCIAL STATEMENTS {CONTINUED)
FOR THE YEAR EPIDED 30 SEPTEMBER 2021
AccouDling policies
ICoTrts"nuedl
1.5 Expendilure
Expenditure is rec￿lsed the ac(¥uaLs basi&
Fundraising costs we those inojrred n genera¥9 fi￿d$ th) not In¢￿de ts rg)sis of dbssemin81ing
information in support of the chariiatle actr4itss.
Swjort we those ￿st incurrèd (lirtdly in support d expenditLYÈ olthÈ obs•ets olthe charity.
Overtp¥d costs area1r￿aIed w the basis of the •du*.spend ty aclivity.
1A Cash and cash equivalents
Cash and eash equwalents indude cash in hand. deposits hehj al call with banks. olher 5hort-term liwid
investrnents wlh original malurrfies ol th1è8 ￿￿th$ C￿ less. bank ovwdralts. Bank o¥erthafts are shown
within bmwings ￿ ￿[re￿Il￿b￿￿e$.
1.7 Financlal Instruments
Thè eharity has ele(xèd to aprly the pr￿￿$ of Sedion 11 'Bast Financial trtslruments. and Section 12
'Othw Financial Instruments Is5ue5'0fFRS 102 10 01 of its instrum￿1$.
Flnaxial 1nstwwn￿ts 00 rettwised i) the bolart¢e sheet Tkn ￿ charty becomes party to the
Contractual pmwsths of thè *)strLThent
FinancKAI assets and liabilitie5 we offset. wilh the net amount5 wesented n the fnanekal statemthts. when
there is a legally enforceable rwjhl to set off the recowised arno￿t￿ and there is ￿ ntenb.on to settle on a nel
basis tsrto reah'se the a55el 5etUe the SIm￿lane9v￿.
asle finaneialassets
Basic f￿anCial assèts, debtors cash ant1 bank balan￿s. a￿ measured at
transaclion price indu¢&)g transac￿"￿ costs We St￿Se￿en￿ caryi8d at amorbsed ¢))sl ugrg th• effective
interest method unless ihe aryangement constitutes a financing transactk)n. *there the transaclion
measured at Ihe wes&it waJe of the fulwe receip15 disc4JW4ted at a market rate of inleresl. Financial assets
dassified as receiv￿le within oneyear are not armwlised.
L>erecognltkn olllnanc1al&￿ets
Financial assets are t1erecogn*ed *then the (a)ntracbJal rvjhts to the cash IIN5 from the asset expl￿ or
are settled. or wh)en Ihè thaiity tsansfefs the finanoal as5el and SLbstantia#y all the risks and rewafds of
ownership lo anolher entity. tr rf some signfftanl rtsks and rewards of o*mefshp are retained but Control of
the asset has transferred to anothw party tr￿1 1$ able to sew the assel n rts ￿)ti￿ty to an unfelated third party.
Baslc financialliabllits•s
Basic financial IptsI￿e5. induthg L¥etht￿ and bank loans are inknaly reragnised ai transaetith price unless
Ihe arrangement constrtutes a financing transaction. the debt instrument is measured at the present
value of the futurè payments ¢Jiscounted at a market rate of mterest. FinancAal liabilrt￿s classffied as payable
thin one yearare not am(xiised.
Debl instruments we s￿Se$￿• cwried at ￿rtISed c051. usv4 ihe ellecknp mlwes"t ratè
Trad¢ ereditors are c*AigalK)ns to pay for gC￿￿5 ar servrys that have been acwwed ￿ IPie ￿dInary course of
operations from suppliers. Amounts payable are das5if*d as ujrrenl liabl1t￿5 if payment 15 due 7Mlhin cffie
year or less. If not, they are presented as n￿-c￿Tent liablrt*s. Trade ￿drtw$ We reo)9nised Tr)ilially at
IransaiXv)n p￿e and $￿Se(￿le￿IlY measty￿ •t #m￿lsed i))St uwg ts eifecirrt ittwest metho
17-

THE HILARY CRAFf CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
NOTES TO THE FINANCIAL STATEMENTS ICONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2021
Accounting poli¢*s
IConllnu•dJ
Dernc0gJie￿ olfinan¢I*l￿bllffts
Financial Iiabth.t￿ are threcoJni5ed the ctsiitys ethitraclual otAigabons expffe or arè distharged or
cancklled.
1.8 Employee b•nèffts
Thè eost of any unustd hotday ￿trt￿)ent is re￿￿1￿1 in the thè èmpk*JeÈ's servi￿$
recer¥ed.
Ttrmnation benefits art recognised inèdkatety as ￿ expense when thè charity is demonstrabty thmmitttd
to lenninafe Ihe employment of an empbyee ￿ to prov*Je terminakn tenefrts.
1.9 Retirement benefits
Payments to defined contr+￿ retsementbenefft scknies a￿ ￿￿19ed as an expense as they trdll du8.
Ctitital aceouirtlng *stBh*tes and V￿g￿ne￿ts
In Ihe application ol the charitys accOunt￿g polws. the trustees are requi￿ to make judgements, egtwnates
and assumptths a￿)(rt the carrwng amount of assels and tAbilrties that are not iea¢Jity apparent from olher
sowces. The estimate$ and assc<iated a$swnptw)ns are based ￿ hislorral experience and other tsctors ttwt
are 0)nsid￿d to be relewant. Adual results rnay drfer Irom these eslwnates.
The estThates and undertywig assumpti￿$ S￿ on an ongoing b8$is. Rew$k>ns kn 8¢¢cxJntiny
estsmates are ￿cOgnISed ￿ the perk)d in whmth ts eslimatè is revised where the revision affects onty that
perir)d, or in thè pèrb)d of Ihe s•¥iS￿ and fuiur& per￿ the revis#)n affects both curr￿1 and lulurg
w*Jd5.
Th• lrnstees consider there t* t* rKJ crdKal acts)LTh)kng estwrAtes orwdgements math.
Voluntsry Incorne
Tolal Unrestricted RestrKted
hJnds
funtjs
Toial
fun(ts
lunds
2021
2021
2(121
2020
2020
2020
Donalb)n5 and gift$
Fundr¥1$￿9 events
218,494
7.545
52.$45
1,122
271.039
8.&$7
159.116
15.019
174.135
905
226.039
53.667
279.7(
160.021
15.019
17S.040
18-

THE HILARY CRAFf CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
NOTES TO THE FINANCIAL STATEMENTS {CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2021
Inv¢$tsi*nts
Ilnreslrkted UnrestrKted
funds
lunds
2021
2020
Bank acts￿nt s￿tth incenlr
Interest recei*at4e
6.563
20.922
9.828
9.628
27.485
R•ising funds
Unrestricted Unr¢stri¢ted
fitnds
fijnds
2021
2020
Costs of generalwig ¥￿Ur￿
Tra%*llin9 and subSiste￿e
Prinlin9. stat￿nery and F*isi
Fundraising •x￿nSeS
other •xp•ns•s
Advertising
Other fundraislng costs
Staff costs
Insur8n¢e
1.130
1,25S
536
85
834
272
68.545
177
445
66.594
C05tsof generating wluntary incomè
89.459
73,740
19-

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2021
Chaiitabl• a¢liviti•s
UftrnstrlclÈd ftè5trKted
2021
2021
Total
2021
2020
LMTK3 di￿ develwThent
Under51anding the cancw bw¥
PhD and olher sttjdert ￿r$8￿$
ljvafian ¢ancer research
Panueakn"¢ ran¢¢r ￿$¢arth
Cancer slem cells researth
Genetic swilthes
asl caneer ￿$t￿￿
Olher reswch syoied
308.789
XQ.789
124.039
21,835
60,595
19.870
S6.332
23.569
129,136
279,117
16.310
99,393
99,393
23.C64
14.808
14.808
134.S08
428.075
232
134.YJ8
443.094
232
15.019
1.TrJ8.89)
15.019 1.023.918
730.803
Shar* of govtmanee casts (set rK>t* 7)
4.791
1.013.959
15.019 1.028,978
735,594
Anatysls by fund
Unrestricted funds
RestrKted fiJ)ds
1.013.959
1,013.959
15,019
702.751
32.843
15.019
1.013.9S9
15.019 1.028.978
735,594
T.h• other r•s•*th woj•d is mairty li relatbjn to on ttffnour rniuomanagement.
Support Costs
Support Governance
co$ts
2021 Swport costs Governance
cosis
2020
Audit fee5
Bank chargès
ProfessKJnal fees
4.050
4,OSO
483
258
727
283
727
283
2S8
4.791
4,791
Anatysed between
Charitable aclr¥ities
4.791
4.791
Governance cos15 inthde £4,050 12020.. £4.0501 in fektbjn to aL*Jit fees payabk to Ihe aud*or. Thèsè
services were donated by the audrtN hen¢e *e i￿￿lded within vobJiW income.

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER.
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2021
Tntstèes
Ncfft of Truste•s (or ary ￿r$on$ connected *rylh Ihèrn) receivtd any rernunernticm or beneffits the
c*arity duriTrJ Ihe year. A dose famly member cl a truslee VAS remw*rabJ for adm￿lstraINe ser¥ice5
owded in Ihe year t0￿ing £15.OQJ12020'. £15.OCQI.
Th• avera9e monthly rnJmberemFrfoyees du￿n9 kne year was:
2021
lkniber
2020
Mumber
Management
EmployThent co¥lS
2021
2020
Wages and salaries
Social security costs
Olhei pension costs
62.720
2.591
1.283
63.425
3,831
1.289
66.594
68.545
No 8mFloyees had anrvJal remuneration of£e0.0￿ or more.
Many of the research Prohth use of P￿0 stswJ•nts. Acli¢ffi Against CarKer is ￿ffenty f￿)(￿ng a
nwnber of PhD stud￿tshIpS ar¥J fe1kY￿h¥￿ al Irwizl Cdle9e * support the re¥earth work.
10 Debto
2021
2020
Amounts falling due"within one ye•r.
Prepayments and acuueil iwKome
381
381
11 Credltors: amounts f•lkng due wilhin one y
2021
2020
Trwje ¢reth"Icf
OthèrcreditCrf5
Ib.110
1.558
yi.¥yy
78,366
99.633
-21

THE HILARY CRAFT CHARrrABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2021
12 R•stri¢lod funds
The income fvnds of ts chanty indude reslrthd ItThls conytsing the unexpended balance5 of
natN)ns and ￿ tEbJ w typJs1 ts ¥ec* purposes:
PAo¥ement in lund$
&*)¥ement in fund5
1 Cti•b•r2019
1 Ixtrjlw 1020
30 Septefflber
2021
Can￿[ stwn
cels fesearch
Genebc
switches
ast
research
83.052
(23.569> 59.483
53.667
113.150
9,274
{9274>
15,019
15,019
(15.019)
2.326
15.019
132,843}
74.502
53.867
115.019)
113.150
The resewth wryk teww uThkrtaken 15 desu*e(l in d2lail in Ihe Trustees. Rep¢Jt uThJ* ReSe￿h Then*&
13 Deslgnated funts
Out of the lolal funds d £2,225.1))6 availabIe. i￿4uding Lmrestrthd ￿Me. funds have been awarded lo
approved pfoieets planned fijlwe exp*nditure o*r the ￿xI iwo years is cahwlated to t* £1.583.103.
Of this. £113,150 are re5trKted frjnds and É1.489,953 we unrestricted funds.
Desi9naled fvnds aw*ded to pripcls research Ihemes sMwn li the ta￿￿ tekm.
Pfogramrne area
Genelic Switche5
LMTK3
CSCS
UCB
Melasla51S
Tolal
nds desiwal
229.972.37
835,699.03
375.851.76
34,527.05
107,052.82
1.583.103.03
stiiclEd
hr*strictsd
229,972.37
834.199.03
264.201.76
34.527.05
107,052.82
1.469,953￿3
14.53
2.79
3.74
.18
.76
1.500.00
111,650.00
113.150.00

THE HILARY CRAFT CHARITABLE FOUNDATION LIMITED
ACTION AGAINST CANCER
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEhl8ER 2021
14 An*$is ol nètassets betsweèn lunds
Unrestricted Restrtcted
lunds
funds
20
2021
Tolal Unreslrwled Restricted
funds
funds
2020
2020
Total
2021
2020
F￿d balances at 30
September 2021 are
p￿sented by..
Current asset￿{￿aN￿￿$j
2.111,8
113.19) 2225,IX
2.959.807
74.502
3.034.109
2,111.856
"113.150
2.225.OC6 2.959,607
74.502 3.034.109
15 R•lat•d party transadion5
Olher th* 8$ di$cb)sed in NAe 8. there wwe Tr) ifjs(*)sable r*ied partytran5aL*icffls durkng Ihe year P020 .
norel.
16 Cash generated from operatt¢x
2021
2020
DefKal for ihe year
18C6.1031
I6[￿.809)
Adjustm•nts lor.
In￿$t￿ent ineome rewJnised in Ststern￿t ac*NitkS
19.6281
(27.485)
Movements inworking capital".
IDeueasellin¢rease *) ¢yeditors
121.2671
46,tr)8
Cash absorbed by 0￿ratIOnS
1839.*81
{587,6261
17 Analysrs of ¢hange$ In net lunds
The charity h*J no debt durng the ye*.